N2 is not N2 is not N2

被引：0
|
作者：
Hanna, Wael C. [1 ]
机构：
[1] McMaster Univ, Dept Thorac Surg, Hamilton, ON L8N 4A6, Canada
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2015年 / 150卷 / 06期
关键词：
RANDOMIZED CONTROLLED-TRIAL; CELL LUNG-CANCER; CHEMOTHERAPY; RADIOTHERAPY; RESECTION;
D O I：
10.1016/j.jtcvs.2015.06.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1494 / 1495
页数：2
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary
    Argiris, A
    Smith, SM
    Stenson, K
    Mittal, BB
    Pelzer, HJ
    Kies, MS
    Haraf, DJ
    Vokes, EE
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1306 - 1311
  • [32] Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease
    Wang, Lin
    Ye, Guanzhi
    Xue, Liang
    Zhan, Cheng
    Gu, Jie
    Xi, Junjie
    Lin, Zongwu
    Jiang, Wei
    Ge, Di
    Wang, Qun
    CLINICAL LUNG CANCER, 2020, 21 (05) : E423 - E434
  • [33] Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
    Du, Chengli
    Chen, Yunhao
    Zhou, Yuwei
    Zheng, Difang
    Zhao, Jiangang
    Tang, Jie
    Wu, Yihe
    Tu, Zhengliang
    BMC CANCER, 2023, 23 (01)
  • [34] Upfront surgery for N2 NSCLC: a large retrospective multicenter cohort study
    Campisi, Alessio
    Catelli, Chiara
    Gabryel, Piotr
    Giovannetti, Riccardo
    Dell'Amore, Andrea
    Kasprzyk, Mariusz
    Piwkowski, Cezary
    Infante, Maurizio
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2023, 71 (12) : 715 - 722
  • [35] What is the definition of "resectable N2 disease"? - Medical oncologist's view
    Eberhardt, Wilfried E.
    Gauler, Thomas C.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S129 - S130
  • [36] Perioperative therapies in surgical non N2 non-small cell lung cancer
    Ruppert, Anne-Marie
    Lavole, Armelle
    Assouad, Jalal
    Cadranel, Jacques
    Wislez, Marie
    BULLETIN DU CANCER, 2017, 104 (01) : 79 - 85
  • [37] Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer
    Kawasaki, Keishi
    Sato, Yasunori
    Suzuki, Yoshio
    Saito, Haruhisa
    Nomura, Yukihiro
    Yoshida, Yukihiro
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 21 (03) : 217 - 222
  • [38] Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer
    De Craene, Sofie
    Surmont, Veerle
    van Meerbeeck, Jan P.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 102 - 111
  • [39] Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigms
    Spicer, Jonathan D.
    Shewale, Jitesh B.
    Nelson, David B.
    Mitchell, Kyle G.
    Bott, Matthew J.
    Vallieres, Eric
    Wilshire, Candice L.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Jones, David R.
    Darling, Gail E.
    Sepesi, Boris
    ANNALS OF THORACIC SURGERY, 2019, 107 (01): : 277 - 284
  • [40] Comparison of Treatment Strategies for Patients With Clinical Stage T1-3/N2 Lung Cancer
    Cheng, Ya-Fu
    Hung, Wei-Heng
    Chen, Heng-Chung
    Cheng, Ching-Yuan
    Lin, Ching-Hsiung
    Lin, Sheng-Hao
    Wang, Bing-Yen
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (02): : 143 - 150
12345